Author Correction: Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants
These authors contributed equally: Zhiqiang Ku, Xuping Xie, Paul R. Hinton, Xinli LiuTexas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USAZhiqiang Ku, Xiaohua Ye, Hui Deng, Wei Xiong, Junquan Liu, Hang Su, Ningyan Zhang & Zhiqiang AnDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USAXuping Xie, Jing Zou, Yang Liu & Pei-Yong ShiIGM Biosciences, Mountain View, CA, USAPaul R. Hinton, Dean C. Ng, Deepal Pandya, Sachi Rahman, Yu-An Cao, Kevin B. Carlin, Elizabeth J. Haanes, Bruce A. Keyt & Stephen F. CarrollDepartment of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USAXinli Liu & Sujit BiswasInstitute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USAAntonio E. Muruato & Pei-Yong ShiDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USAAntonio E. Muruato & Vineet D. MenacherySealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USAPei-Yong ShiSealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USAPei-Yong ShiDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USAPei-Yong Shi
